Form D — Absco Therapeutics, Inc.
0002023557-25-000004 · filed Aug 27, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $5,000,000
- Reported amount sold
- $5,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Absco Therapeutics, Inc.
- CIK
- 2023557
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 127 WESTERN AVENUE
ALLSTON, MA 02134 - Phone
- 314-917-7620
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Stephen Linderman · Executive OfficerAllston, MA Find on LinkedIn ↗
-
Avik Som · DirectorAllston, MA Find on LinkedIn ↗
-
Carlo Giovanni Traverso · DirectorAllston, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗